Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary-Clinical significance of BRCA2 gene variants in genomically stable tumors.
Gynecol Oncol
; 161(3): 762-768, 2021 06.
Article
in En
| MEDLINE
| ID: mdl-33773808
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Cystadenocarcinoma, Serous
/
Genetic Predisposition to Disease
/
BRCA2 Protein
Type of study:
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Gynecol Oncol
Year:
2021
Type:
Article
Affiliation country:
United States